|
Broadening Our Scientific Workforce
In both the public and private sectors there is ever-increasing awareness
of the benefits of a diverse workforce. Increased diversity brings
with it a more diverse array of perspectives and modes of thinking – both
of which are integral to the scientific process. Simply put, an increased
variety of ideas means an increased potential for solutions. While any organization
would benefit from such increased potential, for NIH the benefit is critical
to its mission of improving worldwide health.
An example of the importance of diverse perspectives in research appears
in the June 2008 publication of the Harvard Business Review, The
Athena Factor: Reversing the Brain Drain in Science, Engineering and Technology (Product No. 10094 at 5-6). When Dr. Sadaf Farooqui was a medical school student
in the United Kingdom, a professor asked her to participate in research investigating
the causes of Sudden Infant Death Syndrome. What was known at the time was
that crib death mortality rates were much lower in the South Asian communities
in the UK than in the country in general. Dr. Farooqui thought, based
on child-rearing practices in Pakistani families that the reason for the lower
mortality rates was that these children sleep on their backs, not on their
stomachs. Research shored up her hypothesis, and the results were published
in the British medical journal, The Lancet. Not long thereafter, the
UK initiated a national campaign to encourage caregivers to put children to
sleep on their backs. In the first year of the initiative, the number
of crib deaths in the UK was cut in half. This is a clear example of
how one investigator’s unique skills and cultural background can make significant contributions to scientific research and policy, and yield tangible benefits to the public.
NIH has focused its diversity efforts on the following groups underrepresented
in the sciences, based on available data and statistics from the National
Science Foundation, and our own experiences in this area:
- Socially, culturally, or educationally disadvantaged populations
- Women at the faculty level and above
- Individuals with disabilities
- Underrepresented racial and ethnic groups
- Families with annual incomes below established low-income thresholds.
Each group faces unique challenges, and many individuals represent an amalgam
of one or more groups. Because of these intricacies, we need to think
“outside of the box” when continuing past efforts, and designing new approaches. For
example, how do we identify persons with unique perspectives? Do we
merely ask persons to check boxes on an application, or do we permit applicants
to elaborate on their backgrounds? There are also more general questions
that are applicable to any population, such as:
- How and why do people choose careers in science?
- What obstacles impede the progress of those pursuing a career in science?
- What is the best role NIH can play in helping create a more diverse scientific
workforce?
A New Year brings not only renewed energy to continue work on ongoing projects,
but also the potential to design new initiatives. In 2009 we will use our
collective resources to better articulate the reasons that scientific workforce
diversity is integral to NIH’s mission, how it can help to eliminate health
disparities, and promote public trust and confidence in our activities. Some
of this work has already begun, with sessions of the December
2008 NIH Summit: The Science of Eliminating Health Disparities dedicated
to examining the nexus between eliminating health disparities and building
the capacity of educational institutions to educate the next generation of
research scientists at the undergraduate, graduate and post-doctorate levels. In
addition, there are several NIH working groups evaluating various facets of
scientific workforce diversity. In the coming months, you will learn
more about these efforts.
The bottom line is that we have much work ahead of us in finding creative
solutions to this issue. However, when our efforts bear fruit, as I strongly
believe they will, the returns to the scientific community will be immeasurable.
I look forward to the coming year and working with you in partnership to enhance
opportunities for tomorrow’s scientific workforce.
- Sally Rockey, Ph.D.
Acting NIH Deputy Director for Extramural Research |
|
Transition to Adobe Forms Officially Under Way
Today, we are happy to announce that NIH has reached a major milestone in
the transition from Grants.gov’s PureEdge-based application forms to their
Adobe-based equivalents.
The transition to Adobe officially began on December 5, 2008, when NIH updated
more than 500 active Funding Opportunity Announcements (FOAs) with Adobe-based
application packages and closed their PureEdge predecessors (NOT-OD-09-026).
The new Adobe forms are required for submission for most receipt dates in
January and beyond. Appointed members of NIH chartered study sections who
utilize alternate plans for submitting R01, R21 and R34 grant applications
as allowed by NIH policy should note that if they are submitting applications
for these grant mechanisms after December 5, they must use the new Adobe forms.
(For more details see NOT-OD-09-028).
There are still a number of active FOAs that will continue to use PureEdge
packages into January 2009, including some FOAs for grant programs with early
December standard receipt dates (small business and conference programs) and
FOAs due to expire in January. In early 2009, the remaining active FOAs with
PureEdge forms will be updated and our transition to Adobe will be complete.
The change was timed (accommodating the error correction window, application
viewing window and late application policy) so that applicants submitting for the final PureEdge standard receipt dates could complete the submission
process using the same form set. NIH aimed to release the new forms in enough
time to provide applicants at least 4 weeks to prepare their Adobe-based applications
for the next receipt dates. The January 7, 2009 receipt date for AIDS and
AIDS-Related Applications will be the first NIH standard receipt date to use the Adobe-based forms. |
Impact on Investigators of Enhancing Peer Review
In response to many comments and much input from the extramural community,
the NIH soon will implement changes to the peer review process. The changes
are centered on three priority areas: (1) engaging the best reviewers, (2)
improving the quality and transparency of review, and (3) ensuring balanced
and fair reviews across scientific fields and career stages. An additional aim is to reduce administrative burden.
The NIH will begin implementing changes in the Fiscal Year 2010 funding cycle. Investigators
submitting applications in January 2009 and later should be aware of the following
new policies.
Shorter Applications.
Shorter applications that align with review criteria will be implemented for
January 2010 receipt dates and beyond.
New Investigator and Early Stage Investigator Policy. NIH intends to support
New Investigators at success rates comparable to those for established investigators
submitting new applications, and Early Stage Investigators should comprise
a majority of the New Investigators. Details are posted in the NIH Guide
(NOT-OD-09-013).
Policy on Resubmission (Amended) Applications. Beginning with original
new applications (i.e., never submitted) and competing renewal applications
submitted for the January 25, 2009 due dates and beyond, the NIH will accept
only a single amendment to the original application. Details are posted
in the NIH Guide (NOT-OD-09-003).
Scoring and Review Criteria. When these applications are reviewed in
May 2009 review meetings, five new policies will be in place: (1) a 9-point
scoring system, (2) enhanced review criteria, (3) formatted reviewer critiques,
(4) scoring of individual review criteria, and (5) clustering of New Investigator
applications during review. Changes to the scoring and review criteria
are described in detail in the NIH Guide, NOT-OD-09-024 and NOT-OD-09-025.
For more details on the implementation timeline, including changes expected
for the Fiscal Year 2011 funding cycle, see the NIH Guide (NOT-09-023). Comprehensive
information on the enhancing peer review effort may be found at http://enhancing-peer-review.nih.gov/.
Below is the updated timeline for implementation of key actions in the NIH
peer review system:
January 2009 Receipt Dates
(FY2010 funding) |
- Revised New and Early Stage Investigator Policies
(NOT-OD-09-013)
- New NIH Policy on Resubmission (Amended) Applications
(NOT-OD-09-003) |
May 2009 Review Meetings
(FY2010 funding) |
- 9-Point Scoring System
- Formatted Reviewer Critiques
- Scoring of Individual Review Criteria
- Enhanced Review Criteria
- Reviewer Toolkit
-
Cluster New Investigator Applications During
Review |
January 2010 Receipt Dates
(FY2011 funding) |
- Shorter applications for R01s and Other Mechanisms
- Restructured Applications to Align with Review Criteria |
|
The NIH Center for Scientific Review (CSR) Updates the Descriptions of its
Chartered Review Panels
In a Guide
Notice released December 10, the NIH Center for Scientific Review (CSR)
announced that it has updated the descriptions of its study sections that
applicants often use to suggest which CSR study section(s) might best review
their applications. These changes only apply to CSR’s chartered study sections,
and they do not apply to other study sections organized by CSR or the other
NIH Institutes or Centers.
CSR revised these study section descriptions in response to requests from
study section chairs and other representatives of the scientific community
who participated in recent evaluations of CSR’s review groups. These changes
were designed to make CSR’s chartered study section descriptions more transparent
and reflective of the types of applications actually reviewed by CSR study
sections. The updated descriptions were also designed to be more user friendly
for applicants—particularly new applicants. |
Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.S., Appointed Director, National Institute of Environmental Health Sciences
Dr. Birnbaum is a toxicologist whose research focuses on the pharmacokinetic
behavior of environmental chemicals; mechanisms of actions of toxicants, including
endocrine disruption; and linking of real-world exposures to health effects. Her
research expertise, extensive activity within the scientific community, and
skills as an administrator and leader will be great assets in her new role directing
NIEHS.
Since 1989 Dr. Birnbaum has worked at the Environmental Protection Agency’s
Office of Research and Development. During that time she has served as a senior
toxicologist in the National Center for Environmental Assessment, the Division
Director for the Experimental Toxicology Division and the Human Studies Division,
and Acting Associate Director for Health of the National Health and Environmental
Effects Research Laboratory.
In his announcement, Dr. Kington also thanked Samuel Wilson, M.D., for his dedicated
service as Acting Director at NIEHS for over a year. |
|
NIH Summit: The Science of Eliminating Health Disparities
As we first mentioned in the July 2008 Extramural Nexus, the NIH
Summit on the Science of Eliminating Health Disparities will take place
from December 14 -18, 2008 at the Gaylord National Resort and Convention
Center in National Harbor, Maryland. Registration is
free.
Join NIH Institutes, Centers, Offices, and their many partners engaged in
research on minority health and health disparities to:
- Highlight the research progress of the NIH on health issues among racial/ethnic
minority and medically underserved populations
- Increase awareness and understanding of disparities in health
- Showcase best-practice models in research, capacity-building, outreach,
and integrated strategies to eliminate health disparities
- Identify strengths and gaps in health disparities research
- Network and dialogue with the nation’s leading experts on minority health
and health disparities
|
Registration is still open for “Molecular Targets for Cancer Prevention”,
Feb 4 and 5, 2009
The Center for Cancer Research and the Division of Cancer Prevention at the
National Cancer Institute will present the symposium Molecular
Targets for Cancer Prevention, February 4 and 5, 2009 at NIH Natcher Conference Center,
Bethesda, Maryland. Evidence from both preclinical and clinical studies will
provide an exciting forum for timely discussion and debate on the state-of-the-science,
recent advances, and opportunities for discovery. Please register for
this symposium at: http://web.ncifcrf.gov/events/cancerprevention/2009/default.asp |
RCDC, NIH RePORTing and You
For many months, the NIH has been explaining the new Research, Condition,
and Disease Categorization (RCDC) project and how it will change the way we
report on the research we fund. RCDC is part of a wider NIH effort to
enhance public accessibility to reports, data, and analyses of NIH research
activities.
We recently launched a new Web site called
RePORT (the Research Portfolio Online Reporting
Tool). RePORT gives the public a single access point to quickly
and easily find data, including information on NIH expenditures and the results
of NIH-supported research. RCDC results will show the amount NIH funded
in each of the same 215 categories it has historically reported to Congress
and the public. The results will be accessible through the RePORT Web
site. Each category will provide detailed information, including for
the first time a complete list of all NIH-funded projects included in that
category.
To find out more about “RCDC, NIH RePORTing and You,” please attend our open
house meeting on the NIH main campus or watch the simultaneous nationwide
webcast on Wednesday, January 14, 2009 from 1:30 – 3:00 pm. During
the 90-minute session, NIH staff will present the new Research Portfolio Online
Reporting Tool (RePORT), demonstrate RCDC, and respond to audience questions.
These new tools provide access to reports, data, and analyses of NIH research
activities, including information on NIH expenditures and the results of NIH-supported
research.
Learn more about the webcast. Be sure to check back periodically for updates. |
Make Plans to Attend a 2009 NIH Regional Seminar on Program Funding and Grants
Administration
What is a NIH Regional Seminar?
Held twice a year, the NIH Regional Seminars
are intended to help demystify the application and review process, clarify
federal regulations and policies, and highlight current areas of special interest
or concern. NIH policy officials, grants management and program staff, as
well as representatives from the Office for Human Research Protections and
the Office of Laboratory Animal Welfare, will interact with seminar participants
and provide a broad array of expertise. Optional eRA Hands-On Computer Workshops
provide the latest information on interacting with NIH electronically.
Who Attends?
This seminar is for you if you're looking for a better understanding
of and the latest changes to elements of the NIH Grants Process, as well as
the opportunity to network with others in their field and NIH/HHS experts.
Where, When, & How Do I Register?
Atlanta, Georgia -
Wednesday, April 15: eRA Hands-On Computer Workshops
Thursday, April 16 & Friday,
April 17: 2-Day Regional Seminar
Registration: (Registration open now)
*Co-hosted by Georgia State University and Georgia Institute
of Technology
Las Vegas, Nevada -
Wednesday, June 24: eRA Hands-On Computer Workshops
Thursday, June 25 & Friday,
June 26: 2-Day Regional Seminar
Registration:
(Registration opens late December 2008)
*Co-ambassadors are the University of
Nevada, Las Vegas and the University of Nevada, Reno
Additional Information?
NIH
Guide Notice
NIH Regional Seminar home page
We hope to see you there! |
|